If you are diagnosed with prostate cancer, your physician will attempt to determine the risk that your disease will be harmful to you in the future. In order to estimate the risk, your physician will take into account your PSA level, clinical stage based on your digital rectal exam and your Gleason score, which is explained below. The levels of risk-low, intermediate and high- are explained below:
If your biopsy is positive, it will be classified using the Gleason grading system. This will assist doctors in choosing the best treatment options and predicting how quickly the cancer is growing.
Prostate cancer contains several types of cells. The Gleason system uses the numbers 1 to 5 to grade the most common (primary) and next most common (secondary) cell types found in the biopsy sample. The sum of these two numbers is the Gleason score, which tells you how aggressive the tumor is. The higher the Gleason score, the more aggressive the cancer.
Gleason grades 1 and 2 are rarely seen since these changes are now usually classified as benign or are located at the center of the gland and remain undiscovered. That means the usual lowest grade is 3. Gleason scores of:
If the prostate cancer is determined to be intermediate or high risk, imaging tests such as bone scans and CAT or MRI scans may be ordered to determine if the cancer has spread.
Altogether, the disease risk status and imaging results will help your doctor plan the best treatment.